CYBERNETIC DIALYSIS Trademark

Trademark Overview

On Thursday, April 28, 2022, a trademark application was filed for CYBERNETIC DIALYSIS with the United States Patent and Trademark Office. The USPTO has given the CYBERNETIC DIALYSIS trademark a serial number of 97386007. The federal status of this trademark filing is SECOND EXTENSION - GRANTED as of Tuesday, June 25, 2024. This trademark is owned by Inncelerex LLC. The CYBERNETIC DIALYSIS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Scientific and medical research services, namely, experimentation, modeling, and simulation services in the field of pharmacology and drug development
cybernetic dialysis

General Information

Serial Number97386007
Word MarkCYBERNETIC DIALYSIS
Filing DateThursday, April 28, 2022
Status731 - SECOND EXTENSION - GRANTED
Status DateTuesday, June 25, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 16, 2023

Trademark Statements

NOT AVAILABLE"DIALYSIS"
Goods and ServicesScientific and medical research services, namely, experimentation, modeling, and simulation services in the field of pharmacology and drug development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 3, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameInncelerex LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressEdgewater, NJ 07020
Party NameInncelerex LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressEdgewater, NJ 07020

Trademark Events

Event DateEvent Description
Monday, May 2, 2022NEW APPLICATION ENTERED
Tuesday, May 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, October 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, October 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Tuesday, February 21, 2023NON-FINAL ACTION WRITTEN
Tuesday, February 21, 2023NON-FINAL ACTION E-MAILED
Tuesday, February 21, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, March 31, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, March 31, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 1, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 10, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 26, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 16, 2023PUBLISHED FOR OPPOSITION
Friday, December 15, 2023SOU EXTENSION 1 GRANTED
Tuesday, May 16, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 11, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, December 15, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 15, 2023SOU EXTENSION 1 FILED
Tuesday, December 19, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 25, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, June 25, 2024SOU EXTENSION 2 FILED
Tuesday, June 25, 2024SOU EXTENSION 2 GRANTED
Tuesday, June 25, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Related Keywords

dialysis cybernetic services pharmacology field drug development simulation experimentation medical research namely